• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, July 21, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

EssilorLuxottica to acquire EyeQ Optometrists

by Myles Hume
January 10, 2024
in Company updates & acquisitions, Local, News, Ophthalmic insights, Ophthalmic organisations, Optometry networks
Reading Time: 3 mins read
A A
EyeQ had several approaches from interested parties regarding amalgamation, merging and acquisition. Image: EyeQ Optometrists

EyeQ had several approaches from interested parties regarding amalgamation, merging and acquisition. Image: EyeQ Optometrists

Share on FacebookShare on Twitter

 

The EyeQ Optometrists network is being sold to EssilorLuxottica, in a significant deal involving 25 practices.

On Friday 5 January, it was announced EyeQ Operations Pty Ltd – the owner of EyeQ Optometrists practices – would be purchased by Luxottica Retail Australia Pty Ltd (EssilorLuxottica), subject to the key terms of the transaction being met.

“As EyeQ Optometrists grew in size and reputation, there have been regular approaches from interested parties regarding the potential to amalgamate, merge, or be purchased, to create a larger sustainable business,” EyeQ said in a statement.

“After numerous interactions, EyeQ Optometrists have agreed to a transaction which will be good for the future of the company, their employees and patients.”

EyeQ is currently described as an Australian-owned, optometrist-led company. Founded in 2007, it has been led by a team with extensive optometric experience, with the foundation practices in operation for more than 40 years.

The network has since expanded across the country, with the majority located in NSW where EyeQ has a presence in Sydney and notably down the NSW coast, as well as some regional areas like Bathurst, Young and Cootamundra. EyeQ also has several locations in Victoria, mainly in suburban Melbourne, and one practice in Queensland, ACT and South Australia, respectively, and two in Western Australia.

While the business ownership will change, EyeQ said “significant and important elements will be retained”.

Namely, practice names will not change, with the EyeQ brand remaining in place. EyeQ employees will continue with the business while the EyeQ national office merges in future with the Luxottica support office located in North Sydney.

EyeQ said it had made this decision to ensure the company and employees continued to deliver the same high quality and specialised eyecare for their patients.

“EssilorLuxottica also believes that EyeQ Optometrists has the potential to continue to expand the brand,” EyeQ’s announcement said.

“EyeQ Optometrists see many benefits for the future with the significant resources available through EssilorLuxottica. These also include benefits to EyeQ employees such as broader career opportunities, education, training and volunteer programs, to name just a few.”

In a statement to Insight, EssilorLuxottica confirmed it had signed a conditional sale and purchase agreement to acquire EyeQ Optometrists.

“Given the presence of EyeQ Optometrists stores across the country and the complementary nature of its practice network, this move bolsters EssilorLuxottica’s strategy to invest in and support the retail industry, and at the same time provide premium eyecare services to even more Australians,” the company said. 

EyeQ Optometrists and EssilorLuxottica leadership are working to ensure a smooth transition for the EyeQ business.

More reading

New acquisitions as EyeQ Optometrists unveils strategic change

EyeQ-NOC acquires The Spectacle Site optometry group

EyeQ and NOC end strategic alliance

Related Posts

RANZCO is teaming up with the RACGP to boost the number of practitioners capable of doing intravitreal injections. Image: kerale/shutterstock.com.

GPs to do intravitreal injections to boost remote eyecare access

by Staff Writer
July 20, 2026

More GPs could soon be upskilled to perform intravitreal injections (IVIs) in a bid to bolster treatment access in rural...

Former owners Ian Bluntish and Joanne Thomas (left) have sold their established practice to Tristan Glover. Images: Holdfastbay Optometry.

Passing the torch, with a little help from ProVision

by Rob Mitchell
July 20, 2026

Buying and selling an optometry practice can be fraught with challenges, but two practitioners have successfully managed the process, with...

The Light Adjustable Lens is now available in Australia and New Zealand. Image: RxSight.

Plenty of interest in RxSight’s Light Adjustable Lens at AUSCRS

by Rob Mitchell
July 17, 2026

RxSight believes Australian cataract surgeons are ready to embrace a technology that has already transformed refractive cataract surgery overseas, using...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Products
    • Ophthalmic Treatments
      • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited